arrow
S

Sara Kehlet Watt

novo nordisk a/s
H指数:8
被引数:429

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8)

强化每周一次伊德卡胰岛素治疗联合每周一次司美格鲁肽在2型糖尿病成人中的疗效与安全性:一项单臂、开放标签、治疗至目标、3b期试验(ONWARDS 8)

2026-08-050
OAAI
Continuous Glucose Monitoring Metrics and Continuous Glucose Monitoring–Based Hypoglycemia; Including Duration; in Individuals with Type 1 Diabetes Switching to Once-Weekly Insulin Icodec: A Post Hoc Evaluation of ONWARDS 6

连续血糖监测指标和基于连续血糖监测的低血糖;包括持续时间;在从每周一次胰岛素icodec切换的1型糖尿病患者中:ONWARDS 6的事后评估

2025-07-180
PRE